Real life efficacy of palbociclib and endocrine therapy in HR positive, HER2 negative advanced breast cancer.

CONCLUSION: In a non-selected population of patients with HR + HER2- ABC, the efficacy and safety data are strikingly similar to those previously reported.
PMID: 33242757 [PubMed - as supplied by publisher]

Source: Breast - November 13, 2020 Category: Cancer & Oncology Authors: Porte B, Carton M, Lerebours F, Brain E, Loirat D, Haroun L, Bellesoeur A, Bach Hamba S, Kirova Y, Cottu P Tags: Breast Source Type: research